CSIMarket Company Name, Ticker, Industry, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Purple Biotech Ltd   (PPBT)
Other Ticker:  
 

Cumulative Purple Biotech Ltd 's Working Capital Ratio for Trailing Twelve Months Period

PPBT's Working Capital Ratio for Trailing Twelve Months Period and Current Assets, Current Liabilities growth


Select the Comparisons : Select the Ratio:

PPBT Working Capital Ratio for Trailing Twelve Months Period

 (Dec 31 2022)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2021)
IV. Quarter
Y / Y Current Liabilities Growth 66.07 % 66.07 % 66.07 % 66.07 % 37.19 %
Y / Y Current Assets Growth -51.77 % -51.77 % -51.77 % -51.77 % 16.32 %
Working Capital Ratio for Trailing Twelve Months Period 4.71 6.64 9.04 12.12 16.22
Total Ranking # 1002 # 717 # 649 # 488 # 345
Seq. Current Liabilities Growth 0 % 0 % 0 % 66.07 % 0 %
Seq. Current Assets Growth 0 % 0 % 0 % -51.77 % 0 %

PPBT Segments >> Back to PPBT Financial Strength Comparisons >> Compare PPBT Debt to Equity Ratio to its Competitors

Working Capital Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Dec 31 2022
On the trailing twelve months basis Due to unchange in Current Liabilities in the IV. Quarter to $7 millions, average cumulative Working Capital Ratio for Trailing Twelve Months Period decreased to 4.71 below Purple Biotech Ltd average Working Capital Ratio for Trailing Twelve Months Period.
Working Capital Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Major Pharmaceutical Preparations industry 301 other companies have achieved higher Working Capital Ratio for Trailing Twelve Months Period than Purple Biotech Ltd . While overall ranking remained unchanged compare to previous quarter at no. .

What is Working Capital Ratio?
More about PPBT
Working Capital Ratio PPBT in the most recent quarter
Working Capital Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 302
Sector # 547
S&P 500 # 995


Working Capital Ratio for Trailing Twelve Months Period Statistics
High Average Low
19.14 9.27 2.34
(Dec 31 2020)   (Dec 31 2019)




Companies with similar average Working Capital Ratio for Trailing Twelve Months Period for 12 months ending Dec 31 2022, within Major Pharmaceutical Preparations Industry Working Capital Ratio for Trailing Twelve Months Period
Pliant Therapeutics Inc   12.92 
Processa Pharmaceuticals Inc   12.79 
Reviva Pharmaceuticals Holdings Inc   12.77 
Acasti Pharma Inc   12.61 
Moonlake Immunotherapeutics  12.56 
Rocket Pharmaceuticals Inc   12.46 
Relmada Therapeutics Inc   12.38 
Longboard Pharmaceuticals Inc   12.33 
Ayala Pharmaceuticals Inc   12.28 
Aldeyra Therapeutics Inc   12.28 
Annexon Inc   12.25 
Pds Biotechnology Corp  12.18 
Moleculin Biotech Inc   12.16 
Tyme Technologies Inc.  12.11 
Dyne Therapeutics Inc   12.10 
Arcutis Biotherapeutics Inc   12.01 
United Therapeutics Corporation  11.96 
Akero Therapeutics Inc   11.96 
Avidity Biosciences Inc   11.95 
Aurinia Pharmaceuticals Inc   11.88 
Chemomab Therapeutics Ltd   11.86 
Cormedix Inc   11.81 
Cytokinetics Incorporated  11.75 
Oncternal Therapeutics Inc   11.70 
Enanta Pharmaceuticals Inc  11.64 
Pepgen Inc   11.49 
Cogent Biosciences Inc   11.47 
Connect Biopharma Holdings Limited  11.45 
Diffusion Pharmaceuticals Inc   11.38 
Painreform Ltd  11.37 




Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com